• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Gabai-Pinsky Veronique exercised 1,500 shares at a strike of $62.18 and sold $183,223 worth of shares (1,500 units at $122.15) (SEC Form 4)

    5/14/25 4:21:51 PM ET
    $IPAR
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $IPAR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Gabai-Pinsky Veronique

    (Last) (First) (Middle)
    200 EAST END AVE

    (Street)
    NEW YORK NY 10128

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    INTERPARFUMS INC [ IPAR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/13/2025 M 1,500 A $62.18 1,500 D
    Common Stock 05/13/2025 S 1,500 D $122.1485 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Option-right to buy $62.18 05/13/2025 M 375 02/01/2022 01/31/2026 Common Stock 375 $0 0 D
    Option-right to buy $62.18 05/13/2025 M 375 02/01/2023 01/31/2026 Common Stock 375 $0 0 D
    Option-right to buy $62.18 05/13/2025 M 375 02/01/2024 01/31/2026 Common Stock 375 $0 0 D
    Option-right to buy $62.18 05/13/2025 M 375 02/01/2025 01/31/2026 Common Stock 375 $0 0 D
    Option-right to buy $97.84 12/31/2023 12/30/2028 Common Stock 300 300 D
    Option-right to buy $97.84 12/31/2024 12/30/2028 Common Stock 300 300 D
    Option-right to buy $97.84 12/31/2025 12/30/2028 Common Stock 300 300 D
    Option-right to buy $97.84 12/31/2026 12/30/2028 Common Stock 300 300 D
    Option-right to buy $97.84 12/31/2027 12/30/2028 Common Stock 300 300 D
    Option-right to buy $147.71 12/29/2024 12/28/2029 Common Stock 300 300 D
    Option-right to buy $147.71 12/29/2025 12/28/2029 Common Stock 300 300 D
    Option-right to buy $147.71 12/29/2026 12/28/2029 Common Stock 300 300 D
    Option-right to buy $147.71 12/29/2027 12/28/2029 Common Stock 300 300 D
    Option-right to buy $147.71 12/29/2028 12/28/2029 Common Stock 300 300 D
    Option-right to buy $130.6 12/31/2025 12/30/2030 Common Stock 300 300 D
    Option-right to buy $130.6 12/31/2026 12/30/2030 Common Stock 300 300 D
    Option-right to buy $130.6 12/31/2027 12/30/2030 Common Stock 300 300 D
    Option-right to buy $130.6 12/31/2028 12/30/2030 Common Stock 300 300 D
    Option-right to buy $130.6 12/31/2029 12/30/2030 Common Stock 300 300 D
    Explanation of Responses:
    /s/ Veronique Gabai-Pinsky by Joseph A. Caccamo, as attorney-in-fact 05/14/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IPAR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IPAR

    DatePrice TargetRatingAnalyst
    1/16/2025$158.00Buy
    Canaccord Genuity
    7/12/2024$140.00Hold → Buy
    Jefferies
    9/9/2022$102.00Overweight
    Piper Sandler
    5/16/2022$99.00Neutral → Buy
    Citigroup
    3/3/2022$104.00 → $99.00Neutral
    Citigroup
    12/10/2021$129.00 → $131.00Buy
    DA Davidson
    11/29/2021$120.00 → $125.00Buy
    BWS Financial
    11/18/2021$100.00 → $104.00Neutral
    Citigroup
    More analyst ratings

    $IPAR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Interparfums, Inc. Reports 2025 First Quarter Results

      NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the first quarter ended March 31, 2025. First Quarter Highlights: ($ in millions, except per share amounts)Three Months EndedMarch 31,20252024% ChangeNet Sales$339$3245%Gross Margin63.7%62.5%+120 bpsOperating Income$75$6810%Operating Margin22.2%21.0%+120 bpsNet Income attributable to Interparfums, Inc.$42$414%Diluted EPS$1.32$1.274%The average dollar/euro exchange rate for the 2025 first quarter was 1.05 compared to 1.09 in the 2024 first quarter leading to a negative 1% foreign exchange impact on sales. Operational CommentaryJean Madar, Chairman & Chief Executive Officer of Interpa

      5/5/25 4:15:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Interparfums, Inc. Reports Record 2025 First Quarter Sales

      Reaffirms FY2025 Guidance2025 First Quarter Conference Call Scheduled for May 6, 2025 NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) ("Interparfums" or the "Company") today announced that for the three months ended March 31, 2025, net sales rose to $339 million, up 5% from $324 million in the first quarter of 2024. Net Sales ($ in millions)Three Months EndedMarch 31, 20252024% ChangeTotal Interparfums, Inc.$339$3245%European based net sales$248$2317%United States based net sales*$94$96(1%)Elimination of intercompany sales ($3)($3)flat*United States based organic net sales increased by 3%, excluding the impact of the discontinued Dunhill license.The avera

      4/23/25 4:15:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Interparfums, Inc. Announces Acquisition of the Goutal Brand

      NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) ("Interparfums" or the "Company") today announced that its subsidiary, Interparfums SA, has acquired all worldwide intellectual property rights relating to Maison Goutal held by Amorepacific Europe. Amorepacific Europe will continue to operate the Goutal Brand under a license agreement for a set duration. Interparfums SA will develop the brand from 2026 onwards, together with its licensee. Created by Annick Goutal in 1981, the eponymous brand positioned itself from the start in the exclusive high-end segment with the launch of the L'Eau d'Hadrien line and the opening of a first boutique on Rue de Bellechasse

      3/17/25 4:15:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Madar Jean sold $1,679,205 worth of shares (13,000 units at $129.17) (SEC Form 4)

      4 - INTERPARFUMS INC (0000822663) (Issuer)

      5/23/25 4:27:09 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Director Gabai-Pinsky Veronique exercised 1,500 shares at a strike of $62.18 and sold $183,223 worth of shares (1,500 units at $122.15) (SEC Form 4)

      4 - INTERPARFUMS INC (0000822663) (Issuer)

      5/14/25 4:21:51 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Amendment: SEC Form 4 filed by CEO Madar Jean

      4/A - INTERPARFUMS INC (0000822663) (Issuer)

      4/29/25 4:20:40 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Inter Parfums Inc. (Amendment)

      SC 13G/A - INTER PARFUMS INC (0000822663) (Subject)

      2/14/23 10:27:53 AM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Inter Parfums Inc. (Amendment)

      SC 13G/A - INTER PARFUMS INC (0000822663) (Subject)

      2/14/22 12:14:51 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Inter Parfums Inc. (Amendment)

      SC 13G/A - INTER PARFUMS INC (0000822663) (Subject)

      2/10/22 8:17:17 AM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    SEC Filings

    See more
    • Interparfums Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - INTERPARFUMS INC (0000822663) (Filer)

      5/5/25 4:52:44 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by Interparfums Inc.

      10-Q - INTERPARFUMS INC (0000822663) (Filer)

      5/5/25 4:39:01 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Interparfums Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTERPARFUMS INC (0000822663) (Filer)

      4/23/25 4:28:01 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Interparfums with a new price target

      Canaccord Genuity initiated coverage of Interparfums with a rating of Buy and set a new price target of $158.00

      1/16/25 7:46:34 AM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Inter Parfums upgraded by Jefferies with a new price target

      Jefferies upgraded Inter Parfums from Hold to Buy and set a new price target of $140.00

      7/12/24 7:30:35 AM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Piper Sandler initiated coverage on Inter Parfums with a new price target

      Piper Sandler initiated coverage of Inter Parfums with a rating of Overweight and set a new price target of $102.00

      9/9/22 7:22:54 AM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    Financials

    Live finance-specific insights

    See more
    • Interparfums, Inc. Reports 2025 First Quarter Results

      NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the first quarter ended March 31, 2025. First Quarter Highlights: ($ in millions, except per share amounts)Three Months EndedMarch 31,20252024% ChangeNet Sales$339$3245%Gross Margin63.7%62.5%+120 bpsOperating Income$75$6810%Operating Margin22.2%21.0%+120 bpsNet Income attributable to Interparfums, Inc.$42$414%Diluted EPS$1.32$1.274%The average dollar/euro exchange rate for the 2025 first quarter was 1.05 compared to 1.09 in the 2024 first quarter leading to a negative 1% foreign exchange impact on sales. Operational CommentaryJean Madar, Chairman & Chief Executive Officer of Interpa

      5/5/25 4:15:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Interparfums, Inc. Reports Record 2025 First Quarter Sales

      Reaffirms FY2025 Guidance2025 First Quarter Conference Call Scheduled for May 6, 2025 NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) ("Interparfums" or the "Company") today announced that for the three months ended March 31, 2025, net sales rose to $339 million, up 5% from $324 million in the first quarter of 2024. Net Sales ($ in millions)Three Months EndedMarch 31, 20252024% ChangeTotal Interparfums, Inc.$339$3245%European based net sales$248$2317%United States based net sales*$94$96(1%)Elimination of intercompany sales ($3)($3)flat*United States based organic net sales increased by 3%, excluding the impact of the discontinued Dunhill license.The avera

      4/23/25 4:15:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary
    • Interparfums, Inc. Reports Record 2024 Fourth Quarter and Full Year Results

      Achieves Diluted EPS of $5.12;Diluted EPS Before Impairment of $5.18 Exceeds Expectations;Reaffirms 2025 Guidance and Announces 7% Increase in Cash Dividend NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported record results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter & Full Year Highlights: ($ in millions, except per share amounts)Three Months EndedDecember 31,Year EndedDecember 31,20242023% Change20242023% ChangeNet Sales$362$32910%$1,452$1,31810%Gross Margin64.5%64.7%(20 bps)63.9%63.7%+20 bpsOperating Income before impairment loss $40$19112%$279$25111%Operating Margin before impairment loss11.1%5.7%+530 bps19.2

      2/25/25 4:05:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary

    $IPAR
    Leadership Updates

    Live Leadership Updates

    See more
    • Inter Parfums, Inc. Announces Retirement of Russell Greenberg to Be Succeeded by Michel Atwood as Chief Financial Officer

      Inter Parfums, Inc. (NASDAQ GS: IPAR) today announced that Russell Greenberg, Executive Vice President and Chief Financial Officer, will retire on September 6, 2022, and will be succeeded by Michel Atwood, a seasoned fragrance and finance executive, as Chief Financial Officer. Mr. Greenberg will stay with the company full time until September 30, 2022 to assist with the transition. Jean Madar, Chairman and Chief Executive Officer, commented, "Russ has played an integral role in the growth and evolution of our company for 30 years. He has been by my side for all the significant initiatives we have undertaken, through the best of times and the most challenging. He has earned, and well deserv

      6/1/22 4:05:00 PM ET
      $IPAR
      Package Goods/Cosmetics
      Consumer Discretionary